p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 601–700 of 1,000
Melanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 47
Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response
Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 56
“For example, with time, these mice may demonstrate a premature aging phenotype, as has been reported in some genetic models of increased p53 activity (32).”
BackgroundAnimal and human models to understand ageing
Lees, H., Walters, H., & Cox, L. S. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.008 · Cited by 56
“tumour suppressor protein p53 appears conserved in mediating senescence, as mice expressing a ‘super-p53’ that is highly active undergo premature ageing [74].”
BackgroundAging and Impairment of Innate Immunity
Nomellini, V., Gomez, C. R., & Kovacs, E. J. (2008) · Contributions to Microbiology · doi:10.1159/000136358 · Cited by 47
A-type nuclear lamins, progerias and other degenerative disorders
Smith, E. D., Kudlow, B. A., Frock, R. L., & Kennedy, B. K. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.10.006 · Cited by 47
“It should be noted that pRB has not been directly linked to aging in the organism, although ‘‘superactive’’ alleles of p53 (Table 2 ), another tumor suppressor whose activity is important for the senescent program, are reported to result in progeroid phenotypes in transgenic mice (Tyner et al., 2002).”
BackgroundCellular and Molecular Targets of Protein S -Glutathiolation
Shackelford, R. E., Heinloth, A. N., Heard, S. C., & Paules, R. S. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.940 · Cited by 51
Cell signaling in aging and apoptosis
Suh, Y. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00025-8 · Cited by 52
Yeo, E., & Park, S. C. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00092-1 · Cited by 48
Chaturvedi, V., Sitailo, L. A., Qin, J., Bodner, B. K., Denning, M. F., Curry, J. L., Zhang, W., Brash, D. E., & Nickoloff, B. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208650 · Cited by 51
“These results are consistent with transgenic mice engineered to constitutively activate p53 producing an early senescence-associated phenotype that was particularly evident in the skin (Tyner et al., 2002).”
ResultTan, O. L., & Fleming, J. S. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030460 · Cited by 47
“As the animal ages, the rates of OSE cell division and/or apoptosis may be decreased [12, 35, 36], because wrinkles and layers are rarely observed in 1-mo and 3-mo animals [29].”
Backgroundp53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin
Ehrnhoefer, D. E., Skotte, N. H., Ladha, S., Nguyen, Y. T. N., Qiu, X., Deng, Y., Huynh, K. T., Engemann, S., Nielsen, S. M., Bečanović, K., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt458 · Cited by 56
“Increased p53 activity is associated with a phenotype that is consistent with accelerated aging in vivo (56).”
BackgroundPleiotropic Role of p53 in Injury and Liver Regeneration after Acetaminophen Overdose
Borude, P., Bhushan, B., Gunewardena, S., Akakpo, J., Jaeschke, H., & Apte, U. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.03.006 · Cited by 46
Davis, T., & Kipling, D. (2005) · Biogerontology · doi:10.1007/s10522-005-4901-4 · Cited by 51
“Mice with a constitutively active form of p53 age more quickly, demonstrating a possible role for p53 in mouse ageing (Tyner et al. 2002), although the presence of extra gene copies of wild-type p53 does not change the rate of ageing in mouse (Garcı́a-Cao et al.”
BackgroundAspects of the molecular regulation of early mammalian development
Edwards, R. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62061-5 · Cited by 50
Pathogen evolution in a vaccinated world
Read, A. F., & Mackinnon, M. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0011 · Cited by 51
Hasty, P., & Vijg, J. (2002) · Science · doi:10.1126/science.1071808 · Cited by 53
Stem cell ageing and non-random chromosome segregation
Charville, G. W., & Rando, T. A. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0279 · Cited by 45
Schank, M., Zhao, J., Wang, L., Li, Z., Cao, D., Nguyen, L. N., Dang, X., Khanal, S., Nguyen, L. N. T., Thakuri, B. K. C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03238-7 · Cited by 53
CLCA2 as a p53-Inducible Senescence Mediator
Tanikawa, C., Nakagawa, H., Furukawa, Y., Nakamura, Y., & Matsuda, K. (2012) · Neoplasia · doi:10.1593/neo.111700 · Cited by 48
“reactivation of p53 in murine liver carcinoma cells induced tumor regression through the induction of cellular senescence [24], and mice expressing active mutant p53 displayed an early onset of aging phenotypes [25].”
BackgroundDownregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice
Oh, Y. S., Kim, D. G., Kim, G., Choi, E., Kennedy, B. K., Suh, Y., Park, B. J., & Kim, S. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00614.x · Cited by 45
“activated p53 can induce senescence as well as cell death (Tyner et al., 2002), we investigated whether AIMP3 induces cellular senescence in a p53-dependent manner.”
BackgroundInfluentialAltered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging
Hinkal, G. W., Gatza, C. E., Parikh, N., & Donehower, L. A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.001 · Cited by 45
“Evidence supporting a hyperactive p53 model include (1) in vitro studies showing that the mallele encoded protein binds with high affinity to wildtype p53, and promotes increased wildtype p53 nuclear localization and transcriptional activity on p53 target genes, and (2) in vivo studies of the p53+/m and p53−/m mice sh…”
BackgroundInfluentialSelf-citationThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Hsp90β interacts with MDM2 to suppress p53‐dependent senescence during skeletal muscle regeneration
He, M. Y., Xu, S. B., Qu, Z. H., Guo, Y. M., Liu, X. C., Cong, X. X., Wang, J. F., Low, B. C., Li, L., Wu, Q., et al. (2019) · Aging Cell · doi:10.1111/acel.13003 · Cited by 45
“In vivo activation of p53 not only led to cancer‐free mice but also resulted in premature aging and shortened lifespan (Maier et al., 2004; Tyner et al., 2002).”
BackgroundReplicative senescence and senescence-like state induced in cancer-derived cells
Hwang, E. S. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00102-1 · Cited by 46
Maintaining appearances—The role of p53 in adult neurogenesis
Medrano, S., & Scrable, H. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.194 · Cited by 50
Warner, H. R., & Sierra, F. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00008-3 · Cited by 45
Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner
Wang, M., Brandt, L. T. L., Wang, X., Russell, H., Mitchell, E., Kamimae-Lanning, A. N., Brown, J. M., Dingler, F. A., Garaycoechea, J. I., Isobe, T., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.035 · Cited by 56
An association of Hutchinson–Gilford progeria and malignancy
Shalev, S. A., Sandre‐Giovannoli, A. D., Shani‐Adir, A., & Lévy, N. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31803 · Cited by 47
Aging and cancer cell biology, 2007
Campisi, J. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00292.x · Cited by 44
Hajjar, J. E., Chatoo, W., Hanna, R., Nkanza, P., Tétreault, N., Tse, Y. C., Wong, T. P., Abdouh, M., & Bernier, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-37444-3 · Cited by 52
Modeling the cancer patient with genetically engineered mice
Roberts, R. B., Arteaga, C. L., & Threadgill, D. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00032-7 · Cited by 47
Cox, L. S., & Faragher, R. G. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7123-x · Cited by 44
Allan, G. J., Beattie, J., & Flint, D. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0269 · Cited by 56
“…from Bioscientifica.com at 03/22/2022 03:06:50PM via free access induced in primary cells by the expression of activated oncogenes such as Ras (Serrano et al. 1997) or Raf (Zhu et al. 1998) or by the activation of tumour suppressor genes (Tyner et al. 2002, Jacobs & de Lange 2004).”
Kwon, M.-J., Lee, K.-Y., Lee, H.-W., Kim, J.-H., & Kim, T.-Y. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6035 · Cited by 43
Xie, Q., Gan, L., Wang, J., Wilson, I., & Li, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.03.018 · Cited by 44
“For example, a p53 mutant mouse strain exhibiting augmented p53 function was developed and shown to have enhanced resistance to tumor growth (Tyner et al., 2002).”
BackgroundTransgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 50
Mohler, P. J., Healy, J. A., Xue, H., Puca, A. A., Kline, C. F., Allingham, R. R., Kranias, E. G., Rockman, H. A., & Bennett, V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001051 · Cited by 43
“Hair growth requires functioning stem cells, suggesting these animals may have impaired stem cell regeneration, which can promote premature senescence (Figure 4F) [33].”
Feng, M., Kim, J., Field, K., Reid, C., Chatzistamou, I., & Shim, M. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00041 · Cited by 42
Hamet, P., & Tremblay, J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00294-4 · Cited by 54
The ecology and evolution of antibiotic-resistant bacteria
Bergstrom, C. T., & Feldgarden, M. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0010 · Cited by 50
Debrabant, B., Soerensen, M., Flachsbart, F., Dato, S., Mengel‐From, J., Stevnsner, T., Bohr, V. A., Kruse, T. A., Schreiber, S., Nebel, A., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.299 · Cited by 45
Amidfar, M., Garcez, M. L., & Kim, Y. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110721 · Cited by 45
Chatoo, W., Abdouh, M., & Bernier, G. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3610 · Cited by 42
“For example, mice expressing a constitutively active form of p53 display a premature aging-like phenotype, and overexpression of the short isoform of p53 (p44) also leads to a phenotype of growth suppression and premature aging in mice (43, 63).”
Aging stem cells, latexin, and longevity
Liang, Y., & Zant, G. E. V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.032 · Cited by 50
Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
Kim, J., Vaish, V., Feng, M., Field, K., Chatzistamou, I., & Shim, M. (2016) · Aging · doi:10.18632/aging.101060 · Cited by 41
Shi, Y., Cao, J., Gao, J., Zheng, L., Goodwin, A., An, C. H., Patel, A. S., Lee, J. S., Duncan, S. R., Kaminski, N., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2023oc · Cited by 45
Sanz-Gonzalez, S. M., BARQUIN, L., García-Cao, I., Roqué, M., GONZALEZ, J., Fuster, J. J., CASTELLS, M., FLORES, J., Serrano, M., & Andrés, V. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.002 · Cited by 44
“Remarkably, in contrast to the early ageing phenotype observed in transgenic mice overexpressing deregulated p53 [30] or its naturally occurring N-terminally truncated p44 variant [31], Superp53 mice age normally [29].”
BackgroundTrade-off between cancer and aging: What role do other diseases play?
Yashin, A. I., Ukraintseva, S. V., Akushevich, I. V., Arbeev, K. G., Kulminski, A. M., & Akushevich, L. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.006 · Cited by 43
“Tyner et al. (2002) and Donehower (2002) showed that mice carrying the p53 mutation with a phenotypic effect analogous to the up-regulation of this gene have a lower risk of cancer development but their life span is reduced and accompanied by early tissue atrophy.”
BackgroundLooking for death at the core of life in the light of evolution
Ameisen, J. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401356 · Cited by 47
Involvement of Rel/NF-κB transcription factors in senescence
Gosselin, K., & Abbadie, C. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.007 · Cited by 48
Yang, J., Lu, Y., Yang, P., Chen, Q., Wang, Y., Ding, Q., Xu, T., Li, X., Li, C., Huang, C., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27521 · Cited by 40
“to DNA damage, oncogene activation, and hypoxia (Adamovich, Adler, Meltser, Reuven, & Shaul, 2014; Tyner et al., 2002).”
BackgroundWhy Is Longevity Still a Scientific Mystery? Sirtuins—Past, Present and Future
Ziętara, P., Dziewięcka, M., & Augustyniak, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010728 · Cited by 40
Atamna, H., Atamna, W., Al-Eyd, G., Shanower, G., & Dhahbi, J. M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.004 · Cited by 40
“…activation of the energy and cellular-defense pathways may explain the potent anti-senescence activity of methylene blue Hani Atamna a,b,n, Wafa Atamna b, Ghaith Al-Eyd a, Gregory Shanower b, Joseph M. Dhahbi c a College of Medicine, California University of Science &…”
BackgroundProgressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer
Bai, H., Liu, X., Lin, M., Meng, Y., Tang, R., Guo, Y., Li, N., Clarke, M. F., & Cai, S. (2024) · Nature Communications · doi:10.1038/s41467-024-49106-2 · Cited by 42
“Notably, activation of the NF-kB and p53 pathways correlated with aging phenotypes 50,51 .”
Didier, N., Hourdé, C., Amthor, H., Marazzi, G., & Sassoon, D. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101075 · Cited by 40
“…lifespan (Matheu et al, 2007) whereas chronically elevated levels of activated p53 lead to early onset aging (Cao et al, 2003; Maier et al, 2004; Tyner et al, 2002; Varela et al, 2005; Vogel et al, 1999). p53 is implicated in stem cell regulation (Cicalese et al, 2009; Hong et al, 2009;…”
Cdkn1b overexpression in adult mice alters the balance between genome and tissue ageing
Pruitt, S. C., Freeland, A. L., Rusiniak, M. E., Kunnev, D., & Cady, G. K. (2013) · Nature Communications · doi:10.1038/ncomms3626 · Cited by 46
Heart Failure as an Aging-Related Phenotype: Wnt/β-Catenin Signaling and p53 Pathway
Morita, H., & Komuro, I. (2018) · International Heart Journal · doi:10.1536/ihj.17-519 · Cited by 45
Fischer, F., Grigolon, G., Benner, C., & Ristow, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00017.2021 · Cited by 45
Grillari, J., Katinger, H. W. D., & Voglauer, R. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.07.003 · Cited by 43
Ryan, A. B., Zeitlin, S. O., & Scrable, H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.002 · Cited by 33
“…that has differing activities depending on p53 protein level, the inducing agent, and the cell type. p53 is also involved in lifespan regulation (Tyner et al., 2002; Maier et al., 2004), cell cycle control (Levine, 1997), DNA repair, and apoptosis (Vogelstein et al., 2000; Gomez-Lazaro et al.,…”
BackgroundFoxOs: Unifying Links Between Oxidative Stress and Skeletal Homeostasis
Kousteni, S. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0054-3 · Cited by 47
Insights into Aging Obtained from p53 Mutant Mouse Models
DUMBLE, M., GATZA, C., TYNER, S., VENKATACHALAM, S., & DONEHOWER, L. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.027 · Cited by 40
Self-citationThe Proinflammatory Phenotype of Senescent Cells: The p53‐Mediated ICAM‐1 Expression
Kletsas, D., Pratsinis, H., Mariatos, G., Zacharatos, P., & Gorgoulis, V. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.056 · Cited by 43
Telomere dysfunction and stem cell ageing
Ju, Z., & Rudolph, K. L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.006 · Cited by 48
Oravecz-Wilson, K. I., Kiel, M. J., Li, L., Rao, D. S., Saint‐Dic, D., Kumar, P. D., Provot, M. M., Hankenson, K. D., Reddy, V. N., Lieberman, A. P., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh102 · Cited by 40
“In this regard, a recent report showed that activation of the tumor suppressor gene p53 also led to a hunchback phenotype (29).”
BackgroundStephens, P. (2003) · Springer eBooks · doi:10.1007/978-94-017-0673-5_2 · Cited by 40
Xu, P., Yang, L., Chang, H., Dai, G., Wang, F., Duan, X., Guo, L., Zhang, Y., & Chen, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097283 · Cited by 39
“The tumor suppressor p53 is closely associated with cell proliferation and differentiation, and it can induce apoptosis, cell cycle arrest, or senescence in response to stressors [12,13].”
BackgroundRegulation of senescence by microRNA biogenesis factors
Abdelmohsen, K., Srikantan, S., Kang, M. J., & Gorospe, M. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.003 · Cited by 42
“…of p53 in mice triggered the accumulation of senescent cells in vivo, linked to the premature appearance of age-associated changes, including loss of fertility and subcutaneous fat, osteoporosis, sarcopenia, thinning of the skin, and reduced hair growth (Tyner et al., 2002; Maier et al., 2004).”
BackgroundPalombo, M. R. (2011) · Quaternary International · doi:10.1016/j.quaint.2011.12.019 · Cited by 40
Wang, F., Liu, J., Robbins, D. F., Morris, K., Sit, A., Liu, Y., & Zhao, Y. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0559-8 · Cited by 46
“reduction of simultaneous tumor growth [4] in mouse models.”
p53-dependent transcription can exhibit both on/off and graded response after genotoxic stress
Jõers, A., Jaks, V., Kase, J., & Maimets, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207864 · Cited by 46
“However, recent evidence suggests that there is a trade-off between processes avoiding the cancer and aging (Sharpless and DePinho, 2002; Tyner et al., 2002).”
BackgroundZhang, X., Azhar, G., Furr, M. C., Zhong, Y., & Wei, J. Y. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00631.2002 · Cited by 43
p53mutations associated with aging-related rise in cancer incidence rates
Richardson, R. B. (2013) · Cell Cycle · doi:10.4161/cc.25494 · Cited by 51
Longevity Genes: From Primitive Organisms to Humans
Butler, R. N., Austad, S. N., Barzilai, N., Braun, A., Helfand, S., Larsen, P. L., McCormick, A. M., Perls, T. T., Shuldiner, A. R., Sprott, R. L., et al. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.7.b581 · Cited by 38
Moore, L. M., Lu, X., Ghebranious, N., Tyner, S. D., & Donehower, L. A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.011 · Cited by 40
“These “p53+/ m mice” have one wild-type p53 germ line allele and one truncated “m” allele missing p53 exons 1−6, but retaining exons 7−11 (Tyner et al., 2002).”
BackgroundInfluentialSelf-citationSwitching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Tp53 and its potential therapeutic role as a target in bladder cancer
Ciccarese, C., Massari, F., Blanca, A., Tortora, G., Montironi, R., Cheng, L., Scarpelli, M., Raspollini, M. R., Vau, N., Fonseca, J., et al. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1297798 · Cited by 42
“An emerging issue is that defects in metabolism account for both cancer and aging [22].”
BackgroundAmelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition
Ekpenyong‐Akiba, A. E., Poblocka, M., Althubiti, M., Rada, M., Jurk, D., Germano, S., Kocsis‐Fodor, G., Shi, Y., Canales, J. J., & Macip, S. (2019) · Aging Cell · doi:10.1111/acel.13079 · Cited by 45
“Several mouse models were developed to address this question, with initial reports showing that excessive p53 activity would protect against cancer but lead to premature aging (Maier et al., 2004; Tyner et al., 2002).”
BackgroundDynamic energy budget approaches for modelling organismal ageing
van Leeuwen, I. M. M., Vera, J., & Wolkenhauer, O. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0071 · Cited by 55
Watanabe, K., Shibuya, S., Koyama, H., Ozawa, Y., Toda, T., Yokote, K., & Shimizu, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610998 · Cited by 46
“In a mouse model, p53 activation (p53m allele) by genetic engineering induces accelerated aging including skin atrophy [27].”
BackgroundAging and the programmed death phenomena
Skulachev, V. P. (2003) · Topics in current genetics · doi:10.1007/978-3-540-37005-5_8 · Cited by 48
Autophagy in neuronal cell loss: a road to death
Takács-Vellai, K., Bayci, A., & Vellai, T. (2006) · BioEssays · doi:10.1002/bies.20489 · Cited by 37
Untimely ends and new beginnings in mouse cloning
Perry, A. C. F., & Wakayama, T. (2002) · Nature Genetics · doi:10.1038/ng0302-243 · Cited by 37
Lane, D. P. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh186 · Cited by 39
Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
Aranda-Anzaldo, A., & Dent, M. A. R. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.01.001 · Cited by 36
Matsumoto, R., Fukuoka, H., Iguchi, G., Odake, Y., Yoshida, K., Bando, H., Suda, K., Nishizawa, H., Takahashi, M., Yamada, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140189 · Cited by 36
Wan, C., & Freitas, A. A. (2017) · Artificial Intelligence Review · doi:10.1007/s10462-017-9541-y · Cited by 39
“It is worth mentioning that the Gene Ontology is a very popular bioinformatics resource to specify gene functions, and analyzing data about aging-related genes is important because old age is the greatest risk factor for a large number of diseases (Tyner et al 2002; de Magalh˜aes 2013).”
BackgroundHaploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
Ghosh, S., Wong, S. K. K., Jiang, Z., Liu, B., Wang, Y., Hao, Q., Gorbunova, V. A., Liu, X., & Zhou, Z. (2018) · eLife · doi:10.7554/elife.32127 · Cited by 40
Qiao, W., Yu, S., Sun, H., Chen, L., Wang, R., Wu, X., Goltzman, D., & Miao, D. (2020) · PubMed · Cited by 43
Comparative Oncology: New Insights into an Ancient Disease
Boddy, A. M., Harrison, T. M., & Abegglen, L. M. (2020) · iScience · doi:10.1016/j.isci.2020.101373 · Cited by 42
Vandenberk, B., Brouwers, B. A. H., Hatse, S., & Wildiers, H. P. M. W. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.08.004 · Cited by 40
Huai, J., Firat, E., Nil, A., Million, D., Gaedicke, S., Kanzler, B., Freudenberg, M. A., Endert, P. V., Köhler, G., Pahl, H. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801413105 · Cited by 37
“The abnormalities of TPPII KO mice that coincide with symptoms of immunohematopoietic senescence in mice and humans are also found in part in mice lacking NF- B pathway components (25) and mice with augmented p53 expression (37).”
BackgroundHow hormones mediate trade-offs in human health and disease
Bribiescas, R. G., & Ellison, P. T. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0007 · Cited by 40
Hasty, P. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.036 · Cited by 39
GD3 in cellular ageing and apoptosis
Malisan, F., & Testi, R. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00138-9 · Cited by 37
Carrasco-Garcia, E., Arrizabalaga, O., Serrano, M., Lovell-Badge, R., & Matheu, A. (2015) · Aging Cell · doi:10.1111/acel.12343 · Cited by 35
“In particular, truncated p53 alleles that permanently activate the endogenous p53 protein display accelerated aging (Tyner et al., 2002; Maier et al., 2004) and reduced tissue function and regeneration, which suggests a defect in stem cells activity (Dumble et al.”
BackgroundInfluentialTrade-Offs Between Cancer and Other Diseases: Do They Exist and Influence Longevity?
Ukraintseva, S. V., Arbeev, K. G., Akushevich, I. V., Kulminski, A. M., Arbeeva, L. S., Culminskaya, I. V., Akushevich, L., & Yashin, A. I. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0941 · Cited by 37
“15 Tyner et al. 3 and Donehower 4 showed that mice carrying the p53 mutation with a phenotypic effect analogous to the upregulation of this gene have a lower risk of cancer development, but their life span is reduced and accompanied by early tissue atrophy.”
Hishiya, A., Ito, M., Aburatani, H., Motoyama, N., Ikeda, K., & Watanabe, K. (2005) · Bone · doi:10.1016/j.bone.2005.05.012 · Cited by 35
Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells
Atsumi, Y., Fujimori, H., Fukuda, H., Inase, A., Shinohe, K., Yoshioka, Y., Shikanai, M., Ichijima, Y., Unno, J., Mizutani, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023432 · Cited by 38
Mouse models of senile osteoporosis
Watanabe, K., & Hishiya, A. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.01.006 · Cited by 43
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.